Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma

Condition:   Esophageal Adenocarcinoma
Interventions:   Drug: Pembrolizumab;   Drug: Taxol;   Drug: Carboplatin
Sponsor:   Weill Medical College of Cornell University
Not yet recruiting - verified December 2016

http://ift.tt/2hn6xCg